Cannabis Pharmaceutical Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032
CHAPTER 1. Industry Overview of Cannabis Pharmaceutical Market
1.1. Definition and Scope
1.1.1. Definition of Cannabis Pharmaceutical
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Cannabis Pharmaceutical Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Cannabis Pharmaceutical Market By Product
1.2.3. Cannabis Pharmaceutical Market By Distribution Channel
1.2.4. Cannabis Pharmaceutical Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.1.3. Driver 3
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.2.3. Restraint 3
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.3.3. Opportunity 3
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Cannabis Pharmaceutical Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Cannabis Pharmaceutical Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2023
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Cannabis Pharmaceutical Market By Product
5.1. Introduction
5.2. Cannabis Pharmaceutical Revenue By Product
5.2.1. Cannabis Pharmaceutical Revenue (USD Billion) and Forecast, By Product, 2020-2032
5.2.2. Epidiolex
5.2.2.1. Epidiolex Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Marinol
5.2.3.1. Marinol Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Cesamet
5.2.4.1. Cesamet Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Sativex
5.2.5.1. Sativex Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Cannabis Pharmaceutical Market By Distribution Channel
6.1. Introduction
6.2. Cannabis Pharmaceutical Revenue By Distribution Channel
6.2.1. Cannabis Pharmaceutical Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
6.2.2. Hospital Pharmacy
6.2.2.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Online Pharmacy
6.2.3.1. Online Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Retail Pharmacy
6.2.4.1. Retail Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Cannabis Pharmaceutical Market By Country
7.1. North America Cannabis Pharmaceutical Market Overview
7.2. U.S.
7.2.1. U.S. Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
7.2.2. U.S. Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
7.3. Canada
7.3.1. Canada Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
7.3.2. Canada Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Cannabis Pharmaceutical Market By Country
8.1. Europe Cannabis Pharmaceutical Market Overview
8.2. U.K.
8.2.1. U.K. Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
8.2.2. U.K. Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.3. Germany
8.3.1. Germany Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
8.3.2. Germany Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.4. France
8.4.1. France Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
8.4.2. France Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.5. Spain
8.5.1. Spain Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
8.5.2. Spain Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
8.6.2. Rest of Europe Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia-Pacific Cannabis Pharmaceutical Market By Country
9.1. Asia-Pacific Cannabis Pharmaceutical Market Overview
9.2. China
9.2.1. China Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.2. China Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3. Japan
9.3.1. Japan Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.2. Japan Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.4. India
9.4.1. India Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
9.4.2. India Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.5. Australia
9.5.1. Australia Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
9.5.2. Australia Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.6. South Korea
9.6.1. South Korea Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
9.6.2. South Korea Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
9.7.2. Rest of Asia-Pacific Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.8. Asia-Pacific PEST Analysis
CHAPTER 10. Latin America Cannabis Pharmaceutical Market By Country
10.1. Latin America Cannabis Pharmaceutical Market Overview
10.2. Brazil
10.2.1. Brazil Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.2. Brazil Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3. Mexico
10.3.1. Mexico Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.2. Mexico Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.2. Rest of Latin America Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Cannabis Pharmaceutical Market By Country
11.1. Middle East & Africa Cannabis Pharmaceutical Market Overview
11.2. GCC
11.2.1. GCC Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.2. GCC Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3. South Africa
11.3.1. South Africa Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.2. South Africa Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.2. Rest of Middle East & Africa Cannabis Pharmaceutical Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Cannabis Pharmaceutical Market
12.1. Cannabis Pharmaceutical Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Cannabis Pharmaceutical Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Teva Pharmaceuticals
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2023
13.1.3.2. Teva Pharmaceuticals 2023 Cannabis Pharmaceutical Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. AbbVie Inc.
13.3. Bausch Health
13.4. Cronos Group Inc.
13.5. Benuvia Operations, LLC
13.6. Panaxia Pharmaceuticals
13.7. Canopy Growth Corporation
13.8. Avicanna, Inc
13.9. GW Pharmaceuticals (Jazz Pharmaceuticals)
13.10. CNBX Pharmaceuticals
13.11. Zynerba Pharmaceuticals, Inc.
13.12. Pfizer
13.13. Corbus Pharmaceuticals
Frequently Asked Questions
How big is the cannabis pharmaceutical market?
The cannabis pharmaceutical market size was valued at USD 3.5 billion in 2023.
What is the CAGR of the global cannabis pharmaceutical market from 2024 to 2032?
The CAGR of cannabis pharmaceutical is 58.3% during the analysis period of 2024 to 2032.
Which are the key players in the cannabis pharmaceutical market?
The key players operating in the global market are including Teva Pharmaceuticals, AbbVie Inc., Bausch Health, Cronos Group Inc., Benuvia Operations, LLC, Panaxia Pharmaceuticals, Canopy Growth Corporation, Avicanna, Inc, GW Pharmaceuticals (Jazz Pharmaceuticals), CNBX Pharmaceuticals, Zynerba Pharmaceuticals, Inc., Pfizer, and Corbus Pharmaceuticals.
Which region dominated the global cannabis pharmaceutical market share?
Europe held the dominating position in cannabis pharmaceutical industry during the analysis period of 2024 to 2032.
Which region registered fastest CAGR from 2024 to 2032?
North America region exhibited fastest growing CAGR for market of cannabis pharmaceutical during the analysis period of 2024 to 2032.
What are the current trends and dynamics in the global cannabis pharmaceutical industry?
The current trends and dynamics in the cannabis pharmaceutical industry include increasing acceptance of cannabis for medical use, growing prevalence of chronic diseases and conditions, and advances in cannabis cultivation and processing technologies.
Which product held the maximum share in 2023?
The epidiolex held the maximum share of the cannabis pharmaceutical industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
